Methyl succinate antagonises biguanide‐induced AMPK‐activation and death of pancreatic β‐cells through restoration of mitochondrial electron transfer
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Background and purpose: Two mechanisms have been proposed to explain the insulin‐sensitising properties of metformin in peripheral tissues: (a) inhibition of electron transport chain complex I, and (b) activation of the AMP activated protein kinase (AMPK). However the relationship between these mechanisms and their contribution to β‐cell death and dysfunction in vitro, are currently unclear. Experimental approach: The effects of biguanides (metformin and phenformin) were tested on MIN6 β‐cells and primary FACS‐purified rat β‐cells. Cell metabolism was assessed biochemically and by FACS analysis, and correlated with AMPK phosphorylation state and cell viability, with or without fuel substrates. Key results: In MIN6 cells, metformin reduced mitochondrial complex I activity by up to 44% and a 25% net reduction in mitochondrial reducing potential. In rat β‐cells, metformin caused NAD(P)H accumulation above maximal glucose‐inducible levels, mimicking the effect of rotenone. Drug exposure caused phosphorylation of AMPK on Thr 172 in MIN6 cell extracts, indicative of kinase activation. Methyl succinate, a complex II substrate, appeared to bypass metformin blockade of complex I. This resulted in reduced phosphorylation of AMPK, establishing a link between biguanide‐induced mitochondrial inhibition and AMPK activation. Corresponding assessment of cell death indicated that methyl succinate decreased biguanide toxicity to β‐cells in vitro. Conclusions and implications: AMPK activation can partly be attributed to metformin's inhibitory action on mitochondrial complex I. Anaplerotic fuel metabolism via complex II rescued β‐cells from metformin‐associated toxicity. We propose that utilisation of anaplerotic nutrients may reconcile in vitro and in vivo effects of metformin on the pancreatic β‐cell. British Journal of Pharmacology (2007) 150, 1031–1043. doi:10.1038/sj.bjp.0707189
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · cited 9×
“…of regulatory (g) and catalytic (a) domains separated by a scaffolding subunit (b), and is activated not only by an increase in the AMP/ATP ratio, but also by elevated NAD:NADH ratios and reactive oxygen species (ROS) (Rutter et al., 2003; Rafaeloff-Phail et al., 2004; Kahn et al., 2005).”
BackgroundInfluentialMetformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388 · cited 1×
“It may be a relevant preliminary observation by Evans et al. (2005) that metformin treated type II diabetic patients appear to have a lower risk for cancer development, and that metformin prevented carcinogen-induced malignant lesions in the pancreata of high fat fed hamsters (Schneider et al.,…”
BackgroundOWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157 · cited 12×
“…oxidoreductase activity was measured using the quartz cuvette spectrophotometric technique described by Jewess and Devonshire (1999), and is similar to the methodologies previously applied to metformin inhibition of complex I (El-Mir et al., 2000; Owen et al., 2000; Brunmair et al., 2004).”
BackgroundMethodResultInfluentialShaw, R. J., Kosmatka, M., Bardeesy, N., Hurley, R. L., Witters, L. A., DePinho, R. A., & Cantley, L. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308061100 · Cited by 1,797
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399 · cited 7×
“…oxidoreductase activity was measured using the quartz cuvette spectrophotometric technique described by Jewess and Devonshire (1999), and is similar to the methodologies previously applied to metformin inhibition of complex I (El-Mir et al., 2000; Owen et al., 2000; Brunmair et al., 2004).”
BackgroundMethodResultInfluentialEfficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
DeFronzo, R. A., & Goodman, A. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330902 · Cited by 1,368 · cited 1×
“…actions of biguanides – and not because of a direct effect on the islet – several published human trials on this drug class have demonstrated improved glucose tolerance yet reduced insulin profiles (Grodsky et al., 1963; Abramson and Arky, 1967; Schatz et al., 1972a; Defronzo and Goodman 1995).”
BackgroundBolster, D. R., Crozier, S. J., Kimball, S. R., & Jefferson, L. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200171200 · Cited by 851 · cited 1×
“Long-term cellular changes result from AMPKmediated alteration of specific transcription factors and modulation of the translational machinery (Bolster et al., 2002; Horman et al., 2002; Kimura et al., 2003; Rutter et al., 2003; Kahn et al., 2005).”
BackgroundMusi, N., Hirshman, M. F., Nygren, J., Svanfeldt, M., Bavenholm, P., Rooyackers, O., Zhou, G., Williamson, J. M., Ljunqvist, O., Efendic, S., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2074 · Cited by 806 · cited 2×
“…is consistent with the inhibition of mitochondrial respiration, as AMPK is activated by a number of stimuli which would be expected under this condition: a reduction in ATP:AMP ratio and increased ROS formation (Zhou et al., 2001; Musi et al., 2002; Rutter et al., 2003; Kahn et al., 2005).”
BackgroundThiazolidinediones, Like Metformin, Inhibit Respiratory Complex I
Brunmair, B., Staniek, K., Gras, F., Scharf, N., Althaym, A., Clara, R., Roden, M., Gnaiger, E., Nohl, H., Waldhäusl, W., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1052 · Cited by 521
AMPK, the metabolic syndrome and cancer
Luo, Z., Saha, A. K., Xiang, X., & Ruderman, N. B. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.011 · Cited by 426 · cited 1×
“Although the underlying cause of the discrepancies between the reports of metformin’s effects on apoptosis in b-cells is unknown, it may be related to a dual role for AMPK in growth regulation (Shaw et al., 2004; Luo et al., 2005).”
BackgroundKimura, N., Tokunaga, C., Dalal, S., Richardson, C., Yoshino, K., Hara, K., Kemp, B. E., Witters, L. A., Mimura, O., & Yonezawa, K. (2003) · Genes to Cells · doi:10.1046/j.1365-2443.2003.00615.x · Cited by 372
Sakamoto, K., Göransson, O., Hardie, D. G., & Alessi, D. R. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00074.2004 · Cited by 299 · cited 2×
“muscle), LKB1 was not required for biguanide-induced AMPK activation (Sakamoto et al., 2004).”
Background
Cited by
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Metformin: from mechanisms of action to therapies
Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501
Stephenne, X., Foretz, M., Taleux, N., van der Zon, G. C., Sokal, E., Hue, L., Viollet, B., & Guigas, B. (2011) · Diabetologia · doi:10.1007/s00125-011-2311-5 · Cited by 287
“The mitochondrial respiratory-chain complex 1 is the primary target of metformin The inhibition of the mitochondrial respiratory-chain complex 1 by metformin was first reported in perfused livers and isolated rat hepatocytes by Leverve’s group [12] and later confirmed in various other cellular models by us [21–25] and…”
BackgroundNew mechanisms of metformin action: Focusing on mitochondria and the gut
Hur, K. Y., & Lee, M. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12328 · Cited by 161
Metadata
- Authors
- Hinke, S. A., Martens, G. A., Cai, Y., Finsi, J., Heimberg, H., Pipeleers, D., & Van de Casteele, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2007-04
- Volume
- 150
- Issue
- 8
- Pages
- 1031-1043
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1786380341
- Cited by
- 77
- References
- 12
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.